Elevation of surfactant protein D, a pulmonary disease biomarker, in the sera of uveitis patients with sarcoidosis
- PMID: 20151281
- DOI: 10.1007/s10384-009-0756-6
Elevation of surfactant protein D, a pulmonary disease biomarker, in the sera of uveitis patients with sarcoidosis
Abstract
Purpose: Surfactant protein D (SP-D) is found in the epithelial cells of multiple mucosal surfaces. It is commonly used to diagnose and screen for pulmonary diseases. In the present study, serum levels of SP-D were measured in patients with uveitis to ascertain whether SP-D is a clinically useful laboratory parameter to diagnose sarcoidosis.
Methods: Sera were obtained from 81 patients with sarcoidosis, 16 patients with Behçet disease, 40 patients with HLA-B27 associated uveitis, 50 patients with Vogt-Koyanagi-Harada (VKH) disease, and 33 healthy volunteers. Serum SP-D levels were quantified with an SP-D enzyme immunoassay kit.
Results: In the healthy control subjects, the average serum SP-D level was 39.70 ng/ml; in the uveitis patients with sarcoidosis, the mean serum SP-D level was 57.0 ng/ml, and in the uveitis patients with other etiologies the mean levels were 38.63 ng/ml for Behçet disease, 38.18 ng/ml for HLA-B27 associated uveitis, and 31.32 ng/ml for the VKH patients. The average serum SP-D levels of patients with sarcoidosis were significantly higher than those of patients with any other uveitis etiologies or healthy controls (P < 0.01).
Conclusions: SP-D may be a less invasive and less expensive laboratory examination for sarcoidosis screening. SP-D should be considered as a new laboratory parameter for the diagnosis of uveitis and sarcoidosis.
Similar articles
-
Prominent increase of macrophage migration inhibitory factor in the sera of patients with uveitis.Invest Ophthalmol Vis Sci. 1999 Jan;40(1):247-50. Invest Ophthalmol Vis Sci. 1999. PMID: 9888451
-
Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease.Sarcoidosis Vasc Diffuse Lung Dis. 2016 Oct 7;33(3):224-234. Sarcoidosis Vasc Diffuse Lung Dis. 2016. PMID: 27758987
-
Diagnostic Value of Serum-Soluble Interleukin 2 Receptor Levels vs Angiotensin-Converting Enzyme in Patients With Sarcoidosis-Associated Uveitis.JAMA Ophthalmol. 2017 Dec 1;135(12):1352-1358. doi: 10.1001/jamaophthalmol.2017.4771. JAMA Ophthalmol. 2017. PMID: 29121154 Free PMC article.
-
The association between vitamin D and uveitis: A comprehensive review.Surv Ophthalmol. 2022 Mar-Apr;67(2):321-330. doi: 10.1016/j.survophthal.2021.07.006. Epub 2021 Jul 31. Surv Ophthalmol. 2022. PMID: 34343538 Review.
-
Serum Surfactant Protein D is a Potential Biomarker for Chronic Obstructive Pulmonary Disease: a Systematic Review and Meta-analysis.Clin Lab. 2019 Dec 1;65(12). doi: 10.7754/Clin.Lab.2019.190539. Clin Lab. 2019. PMID: 31850711
Cited by
-
Biomarkers and molecular endotypes of sarcoidosis: lessons from omics and non-omics studies.Front Immunol. 2024 Jan 4;14:1342429. doi: 10.3389/fimmu.2023.1342429. eCollection 2023. Front Immunol. 2024. PMID: 38250062 Free PMC article. Review.
-
An Insight into the Diverse Roles of Surfactant Proteins, SP-A and SP-D in Innate and Adaptive Immunity.Front Immunol. 2012 Jun 7;3:131. doi: 10.3389/fimmu.2012.00131. eCollection 2012. Front Immunol. 2012. PMID: 22701116 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials